Drug Discovery Technology Market was valued at over USD 9 billion in 2015, and is estimated to expand at 8.3% CAGR from 2016 to 2023. Biomarker-directed therapies with drugs targeting epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), c-ros oncogene 1 receptor tyrosine kinase (ROS1) have accelerated the development of novel anticancer drugs.
Hence, precision medicine is an apt approach that will consider individual variability in genes, lifestyles, and environment. This process allows the researcher to analyze the cause of a patient at the molecular level and then use targeted treatments. Expanding precision medicine trials in cancer genomics and technological advancements such as biomarker-based test kits and next generation sequencing will fast-track global precision medicine market growth.
Request for a sample of this research report @https://www.fractovia.org/request-sample/250
Government support for these technologies will further boost precision medicine market scope over the forecast timeframe. For example, Precision Medicine Initiatives (PMI) commenced by U.S President Barack Obama in January 2015, will alter the concept of medicines, revolutionizing the medication and diagnosis perception. This was particularly initiated to expand cancer genomics to develop better prevention and treatment methods. To support the research and regulation of this initiative, US FDA will receive USD 10 million for building the database.
Precision medicine finds wide applications in oncology, immunology, respiratory systems, and central nervous systems. Oncology, which contributed over 30% of the global precision medicine market share in 2015, is expected to record a CAGR of 10.9% over the period of 2016-2023. To optimize the disease management, oncology is utilizing the molecular profile of an individual cancer genome. Precision medicine market revenue in Central Nervous System (CNS) worth USD 9 billion in 2015, is anticipated to grow significantly over the timeframe, owing to its wide application in brain circuitry.
Based on technology, precision medicine market is segmented into big data analytics, drug discovery, gene sequencing, companion diagnostics, and bioinformatics. Drug discovery based precision medicine market worth USD 9 billion in 2015, is anticipated to grow at a rate of 8.3% over the coming seven years. Gene sequencing based precision medicine industry size worth USD 8 billion in 2015, is expected to witness a substantial growth over the timeframe owing to favorable government policies supporting next-generation sequencing research on people’s genes, lifestyles, and environment. Companion diagnostics based precision medicine market is projected to witness a high surge over the next few years, owing to favorable regulatory norms coupled with high government spending encouraging its use.
North American precision medicine market is expected to grow significantly over the coming years due to favorable government regulations. U.S. is predicted to contribute significantly towards the regional share.
Make an inquiry for purchasing this report @https://www.fractovia.org/request-purchase/250
Asia Pacific precision medicine market is projected to witness a significant surge over the timeframe, owing to growing government investments in healthcare sector & medical research. China is expected to be a major regional revenue contributor.
Europe precision medicine industry size worth USD 2.4 billion in 2015, is expected to grow noticeably over 2016-2023, owing to favorable compensation policies. France and Germany are predicted to be the major regional revenue contributors.
Market players will try to increase their revenue through product innovations and high R & D investments. Key precision medicine industry participants include Laboratory Genomics of America Holdings, Intomics A/S, Silicon Biosystems, Eagle Genomics Limited, Roche, Covance, Pfizer, and Quest Diagnostics.
Fractovia.org is one of India's leading in-house and free news portal. It is fully automated, and operates on a constant premise, interfacing with news sites and offering redesigned breaking features to readers across the globe. Our mission is to offer individuals opportunities for connections with news writers and distributors which they can pursue. We operate by mapping articles pertaining to breaking news, constantly and progressively, against a pre-determined word-based theme, offering important connections to readers and clients, as well as distributors.
Corporate Sales, USA
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.